These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8349331)

  • 1. Cardiac weight in hypertension induced by nitric oxide synthase blockade.
    Arnal JF; el Amrani AI; Chatellier G; Ménard J; Michel JB
    Hypertension; 1993 Sep; 22(3):380-7. PubMed ID: 8349331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. L-arginine fails to protect against myocardial remodelling in L-NAME-induced hypertension.
    Simko F; Luptak I; Matuskova J; Krajcirovicova K; Sumbalova Z; Kucharska J; Gvozdjakova A; Simko J; Babal P; Pechanova O; Bernatova I
    Eur J Clin Invest; 2005 Jun; 35(6):362-8. PubMed ID: 15948896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of kinins and nitric oxide in the antihypertrophic effect of ramipril.
    Rhaleb NE; Yang XP; Scicli AG; Carretero OA
    Hypertension; 1994 Jun; 23(6 Pt 2):865-8. PubMed ID: 7515854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regression of chronic L -NAME-treatment-induced left ventricular hypertrophy: effect of captopril.
    Bernátová I; Pechánová O; Pelouch V; Simko F
    J Mol Cell Cardiol; 2000 Feb; 32(2):177-85. PubMed ID: 10722795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discoordinate re-expression of cardiac fetal genes in N(omega)-nitro-L-arginine methyl ester (L-NAME) hypertension.
    Zhang Y; Carreras D; de Bold AJ
    Cardiovasc Res; 2003 Jan; 57(1):158-67. PubMed ID: 12504825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N(G)-nitro-L-arginine methyl ester-induced hypertension and natriuretic peptide gene expression: inhibition by angiotensin II type 1 receptor antagonism.
    Suo M; Kalliovalkama J; Pörsti I; Jolma P; Tolvanen JP; Vuolteenaho O; Ruskoaho H
    J Cardiovasc Pharmacol; 2002 Sep; 40(3):478-86. PubMed ID: 12198334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left ventricular adaptation to chronic pressure overload induced by inhibition of nitric oxide synthase in rats.
    Matsubara BB; Matsubara LS; Zornoff LA; Franco M; Janicki JS
    Basic Res Cardiol; 1998 Jun; 93(3):173-81. PubMed ID: 9689443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic inhibition of nitric oxide synthase induces hypertension and cardiomyocyte mitochondrial and myocardial collagen remodelling in the absence of hypertrophy.
    Rossi MA; Ramos SG; Prado CM
    J Hypertens; 2003 May; 21(5):993-1001. PubMed ID: 12714875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistent hypertension following inhibition of nitric oxide formation in the young Wistar rat: role of renin and vascular hypertrophy.
    Morton JJ; Beattie EC; Speirs A; Gulliver F
    J Hypertens; 1993 Oct; 11(10):1083-8. PubMed ID: 8258672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of nitric oxide in ginsenoside Rg(1)-induced protection against left ventricular hypertrophy produced by abdominal aorta coarctation in rats.
    Deng J; Wang YW; Chen WM; Wu Q; Huang XN
    Biol Pharm Bull; 2010; 33(4):631-5. PubMed ID: 20410597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of cardiomyocyte hypotrophy in rats under prolonged treatment with a low dose of a nitric oxide synthesis inhibitor.
    de Oliveira CF; Cintra KA; Teixeira SA; De Luca IM; Antunes E; De Nucci G
    Eur J Pharmacol; 2000 Mar; 391(1-2):121-6. PubMed ID: 10720643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attenuation of hypertension, cardiomyocyte hypertrophy, and myocardial fibrosis by beta-adrenoceptor blockers in rats under long-term blockade of nitric oxide synthesis.
    Pacca SR; de Azevedo AP; De Oliveira CF; De Luca IM; De Nucci G; Antunes E
    J Cardiovasc Pharmacol; 2002 Feb; 39(2):201-7. PubMed ID: 11791005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ET(A) receptor antagonist ameliorates nephrosclerosis and left ventricular hypertrophy induced in rat by prolonged inhibition of nitric oxide synthesis.
    Nakamura T; Kurashina T; Saito Y; Sumino H; Akuzawa N; Aizawa H; Sakamoto H; Ono Z; Nagai R
    Hypertens Res; 1998 Dec; 21(4):251-7. PubMed ID: 9877518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Captopril prevents NO-deficient hypertension and left ventricular hypertrophy without affecting nitric oxide synthase activity in rats.
    Bernátová I; Pechánová O; Simko F
    Physiol Res; 1996; 45(4):311-6. PubMed ID: 9085355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of nitric oxide on cardiac hormone secretion: effect of NG-nitro-L-arginine methyl ester on atrial natriuretic peptide and brain natriuretic peptide release.
    Leskinen H; Vuolteenaho O; Leppäluoto J; Ruskoaho H
    Endocrinology; 1995 Mar; 136(3):1241-9. PubMed ID: 7867578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular structure and expression of endothelin-1 gene in L-NAME-treated spontaneously hypertensive rats.
    Sventek P; Li JS; Grove K; Deschepper CF; Schiffrin EL
    Hypertension; 1996 Jan; 27(1):49-55. PubMed ID: 8591887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ramipril prevents the detrimental sequels of chronic NO synthase inhibition in rats: hypertension, cardiac hypertrophy and renal insufficiency.
    Hropot M; Grötsch H; Klaus E; Langer KH; Linz W; Wiemer G; Schölkens BA
    Naunyn Schmiedebergs Arch Pharmacol; 1994 Dec; 350(6):646-52. PubMed ID: 7535899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of simvastatin on remodeling of the left ventricle and aorta in L-NAME-induced hypertension.
    Simko F; Matuskova J; Luptak I; Krajcirovicova K; Kucharska J; Gvozdjakova A; Babal P; Pechanova O
    Life Sci; 2004 Jan; 74(10):1211-24. PubMed ID: 14697405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spontaneous, L-arginine-induced and spironolactone-induced regression of protein remodeling of the left ventricle in L-NAME-induced hypertension.
    Simko F; Potácová A; Pelouch V; Paulis L; Matúsková J; Krajcírovicová K; Pechánová O; Adamcová M
    Physiol Res; 2007; 56 Suppl 2():S55-S62. PubMed ID: 17824806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antihypertensive agents prevent nephrosclerosis and left ventricular hypertrophy induced in rats by prolonged inhibition of nitric oxide synthesis.
    Akuzawa N; Nakamura T; Kurashina T; Saito Y; Hoshino J; Sakamoto H; Sumino H; Ono Z; Nagai R
    Am J Hypertens; 1998 Jun; 11(6 Pt 1):697-707. PubMed ID: 9657629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.